Compounds and methods for the treatment of inflammatory diseases of the CNS

Details for Australian Patent Application No. 2009311753 (hide)

Owner Index Pharmaceuticals AB

Inventors Bandholtz, Lisa Charlotta; Gielen, Alexander; Zargari, Arezou; Von Stein, Oliver; Axelsson, Lars-Goran

Agent Shelston IP

Pub. Number AU-A-2009311753

PCT Pub. Number WO2010/053435

Priority 0802339-2 04.11.08 SE; 61/111,287 04.11.08 US

Filing date 4 November 2009

Wipo publication date 14 May 2010

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 April 2011 PCT application entered the National Phase

  PCT publication WO2010/053435 Priority application(s): WO2010/053435

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009311756-Modulators of amyloid beta.

2009311748-Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells